SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-052969
Filing Date
2015-07-24
Accepted
2015-07-24 08:10:39
Documents
12
Period of Report
2015-07-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-16125_18k.htm 8-K 25597
2 EX-99.1 a15-16125_1ex99d1.htm EX-99.1 480115
3 GRAPHIC g161251mm11i001.gif GRAPHIC 1759
4 GRAPHIC g161251mm01i001.jpg GRAPHIC 2013
5 GRAPHIC g161251mm01i002.jpg GRAPHIC 2010
6 GRAPHIC g161251mm03i001.jpg GRAPHIC 2013
7 GRAPHIC g161251mm07i001.gif GRAPHIC 1759
8 GRAPHIC g161251mm07i002.gif GRAPHIC 1754
9 GRAPHIC g161251mm05i001.gif GRAPHIC 1759
10 GRAPHIC g161251mm05i002.gif GRAPHIC 1754
11 GRAPHIC g161251mm09i001.gif GRAPHIC 1759
12 GRAPHIC g161251mm13i001.gif GRAPHIC 1759
  Complete submission text file 0001104659-15-052969.txt   533613
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 151003455
SIC: 2834 Pharmaceutical Preparations